13125 Berlin, de
Eckert & Ziegler to Open up US-Production Site for Yttrium-90
The decision to open a sister plant in the United States was facilitated by a competitor’s decision to close their existing older production line for Y-90 in June later this year. It had already been considered as the next step in Eckert & Ziegler’s global expansion strategy. Previously in 2019 Eckert & Ziegler had agreed to bring its Y-90 production technology to a partner in Chengdu, China, in return giving Eckert & Ziegler long-term, exclusive global marketing and sales rights. Once the Boston plant is operational, Eckert & Ziegler will be able to offer local supply of Y-90 to pharmaceutical companies or hospitals in all regions of the world.
“The geo strategy of Eckert & Ziegler, which offers a reliable, redundant and local supply of high-quality radioisotopes, has hit a nerve in the industry”, explained Dr. Lutz Helmke, member of the Executive Board of Eckert & Ziegler AG. “Our American customers have already committed to procure a substantial part of their demand from the new Boston site, scheduled for full operational readiness in 2021. For the transition period, while the plant is being built, our existing European facility is able to cover any shortfalls”.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to firstname.lastname@example.org.